Skip to main content
Top
Published in: BMC Oral Health 1/2024

Open Access 01-12-2024 | Cytokines | Research

Inflammatory cytokines mediating the effect of oral lichen planus on oral cavity cancer risk: a univariable and multivariable mendelian randomization study

Authors: Tao Zheng, Chengyong Liu, Yetong Wang, Han Zhou, Rong Zhou, Xuan Zhu, Zibing Zhu, Yisi Tan, Zhengrui Li, Xufeng Huang, Jin Tan, Keke Zhu

Published in: BMC Oral Health | Issue 1/2024

Login to get access

Abstract

Background

While observational studies and experimental data suggest a link between oral lichen planus (OLP) and oral cavity cancer (OCC), the causal relationship and the role of inflammatory cytokines remain unclear.

Methods

This study employed a univariable and multivariable Mendelian Randomization (MR) analysis to investigate the causal relationship between OLP and the risk of OCC. Additionally, the potential role of inflammatory cytokines in modulating this association was explored. Instrumental variables were derived from genetic variants associated with OLP (n = 377,277) identified in Finngen R9 datasets, with 41 inflammatory cytokines as potential mediators, and OCC (n = 4,151) as the outcome variable. Analytical methods including Inverse Variance Weighted (IVW), Weighted Median, MR-Egger, and MR-PRESSO were utilized to assess the causal links among OLP, inflammatory cytokines, and OCC risk. Multivariable MR (MVMR) was then applied to quantify the mediating effects of these cytokines in the relationship between OLP and increased OCC risk.

Results

MR analysis provided strong evidence of a causal relationship between OLP (OR = 1.417, 95% CI = 1.167–1.721, p < 0.001) and the risk of OCC. Furthermore, two inflammatory cytokines significantly influenced by OLP, IL-13 (OR = 1.088, 95% CI: 1.007–1.175, P = 0.032) and IL-9 (OR = 1.085, 95% CI: 1.005–1.171, P = 0.037), were identified. Subsequent analysis revealed a significant causal association only between IL-13 (OR = 1.408, 95% CI: 1.147–1.727, P = 0.001) and higher OCC risk, establishing it as a potential mediator. Further, MVMR analysis indicated that IL-13 (OR = 1.437, 95% CI = 1.139–1.815, P = 0.002) mediated the relationship between OLP and OCC, accounting for 8.13% of the mediation.

Conclusion

This study not only elucidates the potential causal relationship between OLP and the risk of OCC but also highlights the pivotal mediating role of IL-13 in this association.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schmitt K, Molfenter B, Laureano NK, Tawk B, Bieg M, Hostench XP, et al. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer. Int J Cancer. 2019;145:3299–310.PubMedCrossRef Schmitt K, Molfenter B, Laureano NK, Tawk B, Bieg M, Hostench XP, et al. Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer. Int J Cancer. 2019;145:3299–310.PubMedCrossRef
2.
go back to reference Bosetti C, Carioli G, Santucci C, Bertuccio P, Gallus S, Garavello W, et al. Global trends in oral and pharyngeal cancer incidence and mortality. Int J Cancer. 2020;147:1040–9.PubMedCrossRef Bosetti C, Carioli G, Santucci C, Bertuccio P, Gallus S, Garavello W, et al. Global trends in oral and pharyngeal cancer incidence and mortality. Int J Cancer. 2020;147:1040–9.PubMedCrossRef
3.
go back to reference Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.PubMedCrossRef Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.PubMedCrossRef
4.
go back to reference Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010;31:100–10.PubMedCrossRef Thun MJ, DeLancey JO, Center MM, Jemal A, Ward EM. The global burden of cancer: priorities for prevention. Carcinogenesis. 2010;31:100–10.PubMedCrossRef
5.
go back to reference Muller S, Tilakaratne WM. Oral potentially malignant disorders. In: Odell EW, editor. Head and neck tumours: Chpt 6: oral cavity and mobile tongue. Lyon: WHO; 2022. Muller S, Tilakaratne WM. Oral potentially malignant disorders. In: Odell EW, editor. Head and neck tumours: Chpt 6: oral cavity and mobile tongue. Lyon: WHO; 2022.
6.
go back to reference El-Howati A, Thornhill MH, Colley HE, Murdoch C. Immune mechanisms in oral lichen planus. Oral Dis. 2023;29:1400–15.PubMedCrossRef El-Howati A, Thornhill MH, Colley HE, Murdoch C. Immune mechanisms in oral lichen planus. Oral Dis. 2023;29:1400–15.PubMedCrossRef
7.
go back to reference Deng X, Wang Y, Jiang L, Li J, Chen Q. Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment. Front Immunol. 2023;13:1023213.PubMedPubMedCentralCrossRef Deng X, Wang Y, Jiang L, Li J, Chen Q. Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment. Front Immunol. 2023;13:1023213.PubMedPubMedCentralCrossRef
8.
go back to reference Carnevale S, Di Ceglie I, Grieco G, Rigatelli A, Bonavita E, Jaillon S. Neutrophil diversity in inflammation and cancer. Front Immunol. 2023;14:1180810.PubMedPubMedCentralCrossRef Carnevale S, Di Ceglie I, Grieco G, Rigatelli A, Bonavita E, Jaillon S. Neutrophil diversity in inflammation and cancer. Front Immunol. 2023;14:1180810.PubMedPubMedCentralCrossRef
9.
go back to reference Gonzalez-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 2008;14:229–43.PubMedCrossRef Gonzalez-Moles MA, Scully C, Gil-Montoya JA. Oral lichen planus: controversies surrounding malignant transformation. Oral Dis. 2008;14:229–43.PubMedCrossRef
10.
go back to reference Idrees M, Kujan O, Shearston K, Farah CS. Oral lichen planus has a very low malignant transformation rate: a systematic review and meta-analysis using strict diagnostic and inclusion criteria. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2021;50:287–98. Idrees M, Kujan O, Shearston K, Farah CS. Oral lichen planus has a very low malignant transformation rate: a systematic review and meta-analysis using strict diagnostic and inclusion criteria. J Oral Pathol Med Off Publ Int Assoc Oral Pathol Am Acad Oral Pathol. 2021;50:287–98.
11.
go back to reference González-Moles MÁ, Ruiz-Ávila I, González-Ruiz L, Ayén Á, Gil-Montoya JA, Ramos-García P. Malignant transformation risk of oral lichen planus: a systematic review and comprehensive meta-analysis. Oral Oncol. 2019;96:121–30.PubMedCrossRef González-Moles MÁ, Ruiz-Ávila I, González-Ruiz L, Ayén Á, Gil-Montoya JA, Ramos-García P. Malignant transformation risk of oral lichen planus: a systematic review and comprehensive meta-analysis. Oral Oncol. 2019;96:121–30.PubMedCrossRef
12.
go back to reference Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol. 2017;68:92–102.PubMedCrossRef Aghbari SMH, Abushouk AI, Attia A, Elmaraezy A, Menshawy A, Ahmed MS, et al. Malignant transformation of oral lichen planus and oral lichenoid lesions: a meta-analysis of 20095 patient data. Oral Oncol. 2017;68:92–102.PubMedCrossRef
13.
go back to reference Wang X, Zhang J, Zhou G. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma. J ORAL Pathol Med. 2021;50:362–70.PubMedCrossRef Wang X, Zhang J, Zhou G. The CXCL11-CXCR3A axis influences the infiltration of CD274 and IDO1 in oral squamous cell carcinoma. J ORAL Pathol Med. 2021;50:362–70.PubMedCrossRef
14.
go back to reference Liu Y, Messadi DV, Wu H, Hu S. Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer. Med Hypotheses. 2010;75:492–4.PubMedPubMedCentralCrossRef Liu Y, Messadi DV, Wu H, Hu S. Oral lichen planus is a unique disease model for studying chronic inflammation and oral cancer. Med Hypotheses. 2010;75:492–4.PubMedPubMedCentralCrossRef
15.
go back to reference Sun Y, Liu N, Guan X, Wu H, Sun Z, Zeng H. Immunosuppression Induced by Chronic Inflammation and the progression to oral squamous cell carcinoma. Mediators Inflamm. 2016;2016:5715719.PubMedPubMedCentralCrossRef Sun Y, Liu N, Guan X, Wu H, Sun Z, Zeng H. Immunosuppression Induced by Chronic Inflammation and the progression to oral squamous cell carcinoma. Mediators Inflamm. 2016;2016:5715719.PubMedPubMedCentralCrossRef
16.
go back to reference Borish L. IL-4 and IL-13 dual antagonism: a promising approach to the dilemma of generating effective asthma biotherapeutics. Am J Respir Crit Care Med. 2010;181:769–70.PubMedCrossRef Borish L. IL-4 and IL-13 dual antagonism: a promising approach to the dilemma of generating effective asthma biotherapeutics. Am J Respir Crit Care Med. 2010;181:769–70.PubMedCrossRef
17.
go back to reference Piccinni M-P, Lombardelli L, Logiodice F, Tesi D, Kullolli O, Biagiotti R, et al. Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Oral Dis. 2014;20:212–8.PubMedCrossRef Piccinni M-P, Lombardelli L, Logiodice F, Tesi D, Kullolli O, Biagiotti R, et al. Potential pathogenetic role of Th17, Th0, and Th2 cells in erosive and reticular oral lichen planus. Oral Dis. 2014;20:212–8.PubMedCrossRef
18.
go back to reference Kioi M, Shimamura T, Nakashima H, Hirota M, Tohnai I, Husain SR, et al. IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma. Int J Cancer. 2009;124:1440–8.PubMedCrossRef Kioi M, Shimamura T, Nakashima H, Hirota M, Tohnai I, Husain SR, et al. IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinoma. Int J Cancer. 2009;124:1440–8.PubMedCrossRef
19.
go back to reference Aziz S, Ahmed SS, Ali A, Khan FA, Zulfiqar G, Iqbal J, et al. Salivary immunosuppressive cytokines IL-10 and IL-13 are significantly elevated in oral squamous cell carcinoma patients. Cancer Invest. 2015;33:318–28.PubMedCrossRef Aziz S, Ahmed SS, Ali A, Khan FA, Zulfiqar G, Iqbal J, et al. Salivary immunosuppressive cytokines IL-10 and IL-13 are significantly elevated in oral squamous cell carcinoma patients. Cancer Invest. 2015;33:318–28.PubMedCrossRef
20.
go back to reference Kwon M, Kim JW, Roh J-L, Park Y, Cho K-J, Choi S-H, et al. Recurrence and cancer-specific survival according to the expression of IL-4Rα and IL-13Rα1 in patients with oral cavity cancer. Eur J Cancer Oxf Engl 1990. 2015;51:177–85. Kwon M, Kim JW, Roh J-L, Park Y, Cho K-J, Choi S-H, et al. Recurrence and cancer-specific survival according to the expression of IL-4Rα and IL-13Rα1 in patients with oral cavity cancer. Eur J Cancer Oxf Engl 1990. 2015;51:177–85.
21.
go back to reference Yin K-J, Huang J-X, Wang P, Yang X-K, Tao S-S, Li H-M, et al. No Genetic Causal Association between Periodontitis and Arthritis: a bidirectional two-sample mendelian randomization analysis. Front Immunol. 2022;13:808832.PubMedPubMedCentralCrossRef Yin K-J, Huang J-X, Wang P, Yang X-K, Tao S-S, Li H-M, et al. No Genetic Causal Association between Periodontitis and Arthritis: a bidirectional two-sample mendelian randomization analysis. Front Immunol. 2022;13:808832.PubMedPubMedCentralCrossRef
22.
go back to reference Xiang M, Wang Y, Gao Z, Wang J, Chen Q, Sun Z, et al. Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: a mendelian randomization. Front Immunol. 2022;13:985729.PubMedCrossRef Xiang M, Wang Y, Gao Z, Wang J, Chen Q, Sun Z, et al. Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: a mendelian randomization. Front Immunol. 2022;13:985729.PubMedCrossRef
23.
go back to reference Dudding T, Johansson M, Thomas SJ, Brennan P, Martin RM, Timpson NJ. Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using mendelian randomization. Int J Cancer. 2018;143:1029–36.PubMedPubMedCentralCrossRef Dudding T, Johansson M, Thomas SJ, Brennan P, Martin RM, Timpson NJ. Assessing the causal association between 25-hydroxyvitamin D and the risk of oral and oropharyngeal cancer using mendelian randomization. Int J Cancer. 2018;143:1029–36.PubMedPubMedCentralCrossRef
24.
go back to reference Gormley M, Dudding T, Sanderson E, Martin RM, Thomas S, Tyrrell J, et al. A multivariable mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat Commun. 2020;11:6071.PubMedPubMedCentralCrossRef Gormley M, Dudding T, Sanderson E, Martin RM, Thomas S, Tyrrell J, et al. A multivariable mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat Commun. 2020;11:6071.PubMedPubMedCentralCrossRef
25.
go back to reference Gormley M, Dudding T, Kachuri L, Burrows K, Chong AHW, Martin RM, et al. Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of mendelian randomization. BMC Med. 2022;20:40.PubMedPubMedCentralCrossRef Gormley M, Dudding T, Kachuri L, Burrows K, Chong AHW, Martin RM, et al. Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of mendelian randomization. BMC Med. 2022;20:40.PubMedPubMedCentralCrossRef
26.
go back to reference Gormley M, Dudding T, Thomas SJ, Tyrrell J, Ness AR, Pring M et al. Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using mendelian randomization. eLife. 2023;12. Gormley M, Dudding T, Thomas SJ, Tyrrell J, Ness AR, Pring M et al. Evaluating the effect of metabolic traits on oral and oropharyngeal cancer risk using mendelian randomization. eLife. 2023;12.
27.
go back to reference Tao H, Yu Z, Dong Y, Liu L, Peng L, Chen X. Lipids, lipid-lowering agents, and inflammatory bowel disease: a mendelian randomization study. Front Immunol. 2023;14:1160312.PubMedPubMedCentralCrossRef Tao H, Yu Z, Dong Y, Liu L, Peng L, Chen X. Lipids, lipid-lowering agents, and inflammatory bowel disease: a mendelian randomization study. Front Immunol. 2023;14:1160312.PubMedPubMedCentralCrossRef
28.
go back to reference Larsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS, et al. Modifiable pathways in Alzheimer’s disease: mendelian randomisation analysis. BMJ. 2017;359:j5375.PubMedPubMedCentralCrossRef Larsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS, et al. Modifiable pathways in Alzheimer’s disease: mendelian randomisation analysis. BMJ. 2017;359:j5375.PubMedPubMedCentralCrossRef
29.
go back to reference Ahola-Olli AV, Würtz P, Havulinna AS, Aalto K, Pitkänen N, Lehtimäki T, et al. Genome-wide Association Study identifies 27 loci influencing concentrations of circulating cytokines and growth factors. Am J Hum Genet. 2017;100:40–50.PubMedCrossRef Ahola-Olli AV, Würtz P, Havulinna AS, Aalto K, Pitkänen N, Lehtimäki T, et al. Genome-wide Association Study identifies 27 loci influencing concentrations of circulating cytokines and growth factors. Am J Hum Genet. 2017;100:40–50.PubMedCrossRef
30.
go back to reference Lesseur C, Diergaarde B, Olshan AF, Wünsch-Filho V, Ness AR, Liu G, et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet. 2016;48:1544–50.PubMedPubMedCentralCrossRef Lesseur C, Diergaarde B, Olshan AF, Wünsch-Filho V, Ness AR, Liu G, et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet. 2016;48:1544–50.PubMedPubMedCentralCrossRef
31.
go back to reference Orrù V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036–45.PubMedPubMedCentralCrossRef Orrù V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036–45.PubMedPubMedCentralCrossRef
32.
go back to reference Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65.PubMedPubMedCentralCrossRef Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65.PubMedPubMedCentralCrossRef
33.
go back to reference Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21:223–42.PubMedPubMedCentralCrossRef Palmer TM, Lawlor DA, Harbord RM, Sheehan NA, Tobias JH, Timpson NJ, et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Stat Methods Med Res. 2012;21:223–42.PubMedPubMedCentralCrossRef
34.
go back to reference Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–14.PubMedPubMedCentralCrossRef Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–14.PubMedPubMedCentralCrossRef
35.
go back to reference Goto A, Yamaji T, Sawada N, Momozawa Y, Kamatani Y, Kubo M, et al. Diabetes and cancer risk: a mendelian randomization study. Int J Cancer. 2020;146:712–9.PubMedCrossRef Goto A, Yamaji T, Sawada N, Momozawa Y, Kamatani Y, Kubo M, et al. Diabetes and cancer risk: a mendelian randomization study. Int J Cancer. 2020;146:712–9.PubMedCrossRef
36.
go back to reference Papadimitriou N, Dimou N, Gill D, Tzoulaki I, Murphy N, Riboli E, et al. Genetically predicted circulating concentrations of micronutrients and risk of breast cancer: a mendelian randomization study. Int J Cancer. 2021;148:646–53.PubMedCrossRef Papadimitriou N, Dimou N, Gill D, Tzoulaki I, Murphy N, Riboli E, et al. Genetically predicted circulating concentrations of micronutrients and risk of breast cancer: a mendelian randomization study. Int J Cancer. 2021;148:646–53.PubMedCrossRef
37.
go back to reference Hazelwood E, Sanderson E, Tan VY, Ruth KS, Frayling TM, Dimou N, et al. Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a mendelian randomization analysis. BMC Med. 2022;20:125.PubMedPubMedCentralCrossRef Hazelwood E, Sanderson E, Tan VY, Ruth KS, Frayling TM, Dimou N, et al. Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a mendelian randomization analysis. BMC Med. 2022;20:125.PubMedPubMedCentralCrossRef
38.
go back to reference Ma W, Zhou X, Huang X, Xiong Y. Causal relationship between body mass index, type 2 diabetes and bone mineral density: mendelian randomization. PLoS ONE. 2023;18:e0290530.PubMedPubMedCentralCrossRef Ma W, Zhou X, Huang X, Xiong Y. Causal relationship between body mass index, type 2 diabetes and bone mineral density: mendelian randomization. PLoS ONE. 2023;18:e0290530.PubMedPubMedCentralCrossRef
39.
go back to reference Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46:207–14.PubMedCrossRef Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol. 2002;46:207–14.PubMedCrossRef
40.
go back to reference Maymone MBC, Greer RO, Kesecker J, Sahitya PC, Burdine LK, Cheng A-D, et al. Premalignant and malignant oral mucosal lesions: clinical and pathological findings. J Am Acad Dermatol. 2019;81:59–71.PubMedCrossRef Maymone MBC, Greer RO, Kesecker J, Sahitya PC, Burdine LK, Cheng A-D, et al. Premalignant and malignant oral mucosal lesions: clinical and pathological findings. J Am Acad Dermatol. 2019;81:59–71.PubMedCrossRef
41.
go back to reference Gandolfo S, Richiardi L, Carrozzo M, Broccoletti R, Carbone M, Pagano M, et al. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol. 2004;40:77–83.PubMedCrossRef Gandolfo S, Richiardi L, Carrozzo M, Broccoletti R, Carbone M, Pagano M, et al. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol. 2004;40:77–83.PubMedCrossRef
42.
go back to reference Arduino PG, Magliano A, Gambino A, Macciotta A, Carbone M, Conrotto D, et al. Risk of Malignant Transformation in 3173 subjects with histopathologically confirmed oral Lichen Planus: a 33-Year Cohort Study in Northern Italy. Cancers. 2021;13:5740.PubMedPubMedCentralCrossRef Arduino PG, Magliano A, Gambino A, Macciotta A, Carbone M, Conrotto D, et al. Risk of Malignant Transformation in 3173 subjects with histopathologically confirmed oral Lichen Planus: a 33-Year Cohort Study in Northern Italy. Cancers. 2021;13:5740.PubMedPubMedCentralCrossRef
43.
go back to reference Tenore G, Mohsen A, Rocchetti F, Rossi G, Cassoni A, Battisti A, et al. Risk of oral squamous cell carcinoma in one hundred patients with oral Lichen Planus: a Follow-Up study of Umberto I University Hospital of Rome. Cancers. 2023;15:3004.PubMedPubMedCentralCrossRef Tenore G, Mohsen A, Rocchetti F, Rossi G, Cassoni A, Battisti A, et al. Risk of oral squamous cell carcinoma in one hundred patients with oral Lichen Planus: a Follow-Up study of Umberto I University Hospital of Rome. Cancers. 2023;15:3004.PubMedPubMedCentralCrossRef
45.
go back to reference Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M, Santoni A, et al. Analysis of the role of chemokines in angiogenesis. J Immunol Methods. 2003;273:83–101.PubMedCrossRef Bernardini G, Ribatti D, Spinetti G, Morbidelli L, Ziche M, Santoni A, et al. Analysis of the role of chemokines in angiogenesis. J Immunol Methods. 2003;273:83–101.PubMedCrossRef
46.
go back to reference Hallett MA, Venmar KT, Fingleton B. Cytokine stimulation of Epithelial Cancer cells: the similar and divergent functions of IL-4 and IL-13. Cancer Res. 2012;72:6338–43.PubMedPubMedCentralCrossRef Hallett MA, Venmar KT, Fingleton B. Cytokine stimulation of Epithelial Cancer cells: the similar and divergent functions of IL-4 and IL-13. Cancer Res. 2012;72:6338–43.PubMedPubMedCentralCrossRef
49.
go back to reference Formentini A, Prokopchuk O, Sträter J, Kleeff J, Grochola LF, Leder G, et al. Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases. Int J Colorectal Dis. 2009;24:57–67.PubMedCrossRef Formentini A, Prokopchuk O, Sträter J, Kleeff J, Grochola LF, Leder G, et al. Interleukin-13 exerts autocrine growth-promoting effects on human pancreatic cancer, and its expression correlates with a propensity for lymph node metastases. Int J Colorectal Dis. 2009;24:57–67.PubMedCrossRef
50.
go back to reference Formentini A, Braun P, Fricke H, Link K-H, Henne-Bruns D, Kornmann M. Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer. Int J Colorectal Dis. 2012;27:1369–76.PubMedCrossRef Formentini A, Braun P, Fricke H, Link K-H, Henne-Bruns D, Kornmann M. Expression of interleukin-4 and interleukin-13 and their receptors in colorectal cancer. Int J Colorectal Dis. 2012;27:1369–76.PubMedCrossRef
51.
go back to reference Lathers DMR, Young MRI. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine. 2004;25:220–8.PubMedCrossRef Lathers DMR, Young MRI. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck. Cytokine. 2004;25:220–8.PubMedCrossRef
52.
go back to reference Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, Bankfalvi A, et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer. 2011;129:2183–93.PubMedCrossRef Trellakis S, Bruderek K, Dumitru CA, Gholaman H, Gu X, Bankfalvi A, et al. Polymorphonuclear granulocytes in human head and neck cancer: enhanced inflammatory activity, modulation by cancer cells and expansion in advanced disease. Int J Cancer. 2011;129:2183–93.PubMedCrossRef
53.
go back to reference Mydlarz WK, Hennessey PT, Wang H, Carvalho AL, Califano JA. Serum biomarkers for detection of head and neck squamous cell carcinoma. Head Neck. 2016;38:9–14.PubMedCrossRef Mydlarz WK, Hennessey PT, Wang H, Carvalho AL, Califano JA. Serum biomarkers for detection of head and neck squamous cell carcinoma. Head Neck. 2016;38:9–14.PubMedCrossRef
54.
go back to reference Sl L, Zs J, La JV, Nm CXQ. H, Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell. 2008;132. Sl L, Zs J, La JV, Nm CXQ. H, Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell. 2008;132.
55.
go back to reference Ito T, Suzuki S, Kanaji S, Shiraishi H, Ohta S, Arima K, et al. Distinct structural requirements for Interleukin-4 (IL-4) and IL-13 binding to the Shared IL-13 receptor facilitate Cellular tuning of Cytokine responsiveness. J Biol Chem. 2009;284:24289–96.PubMedPubMedCentralCrossRef Ito T, Suzuki S, Kanaji S, Shiraishi H, Ohta S, Arima K, et al. Distinct structural requirements for Interleukin-4 (IL-4) and IL-13 binding to the Shared IL-13 receptor facilitate Cellular tuning of Cytokine responsiveness. J Biol Chem. 2009;284:24289–96.PubMedPubMedCentralCrossRef
57.
go back to reference Heller NM, Qi X, Junttila IS, Shirey KA, Vogel SN, Paul WE et al. Type I IL-4Rs selectively activate IRS-2 to induce Target Gene expression in macrophages. Sci Signal. 2008;1. Heller NM, Qi X, Junttila IS, Shirey KA, Vogel SN, Paul WE et al. Type I IL-4Rs selectively activate IRS-2 to induce Target Gene expression in macrophages. Sci Signal. 2008;1.
58.
go back to reference Ko CWS, Cuthbert RJ, Orsi NM, Brooke DA, Perry SL, Markham AF, et al. Lack of interleukin-4 receptor alpha chain-dependent signalling promotes azoxymethane-induced colorectal aberrant crypt focus formation in Balb/c mice. J Pathol. 2008;214:603–9.PubMedCrossRef Ko CWS, Cuthbert RJ, Orsi NM, Brooke DA, Perry SL, Markham AF, et al. Lack of interleukin-4 receptor alpha chain-dependent signalling promotes azoxymethane-induced colorectal aberrant crypt focus formation in Balb/c mice. J Pathol. 2008;214:603–9.PubMedCrossRef
59.
go back to reference Nakashima H, Terabe M, Berzofsky JA, Husain SR, Puri RK. A Novel Combination Immunotherapy for Cancer by IL-13Rα2–Targeted DNA vaccine and Immunotoxin in murine tumor models. J Immunol Baltim Md 1950. 2011;187:4935–46. Nakashima H, Terabe M, Berzofsky JA, Husain SR, Puri RK. A Novel Combination Immunotherapy for Cancer by IL-13Rα2–Targeted DNA vaccine and Immunotoxin in murine tumor models. J Immunol Baltim Md 1950. 2011;187:4935–46.
Metadata
Title
Inflammatory cytokines mediating the effect of oral lichen planus on oral cavity cancer risk: a univariable and multivariable mendelian randomization study
Authors
Tao Zheng
Chengyong Liu
Yetong Wang
Han Zhou
Rong Zhou
Xuan Zhu
Zibing Zhu
Yisi Tan
Zhengrui Li
Xufeng Huang
Jin Tan
Keke Zhu
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2024
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-024-04104-0

Other articles of this Issue 1/2024

BMC Oral Health 1/2024 Go to the issue